المؤلفون: Mark Opdam, Annelot G.J. van Rossum, Marlous Hoogstraat, Gergana Bounova, Hugo M. Horlings, Erik van Werkhoven, Ingrid A.M. Mandjes, A. Elise van Leeuwen – Stok, Sander Canisius, Harm van Tinteren, Alex L.T. Imholz, Johanneke E.A. Portielje, Monique E.M.M. Bos, Sandra Bakker, Jelle Wesseling, Lennart Kester, Jacco van Rheenen, Emiel J. Rutgers, Renee X. de Menezes, Lodewyk F.A. Wessels, Marleen Kok, Hendrika M. Oosterkamp, Sabine C. Linn, Marcel Soesan, Rianne M. Oosterkamp, Frank Jeurissen, Nir Weijl, Karin J. Beelen, Aart van Bochove, Gerty de Klerk, Suzan Vrijaldenhoven, Annette van der Velden, Hiltje de Graaf, Marielle Smeets, Jetske Meerum Terwogt, Jolanda Schrama, Philomeen Kuijer, Hanneke Wilmink, Ronald Hoekstra, Judith Kroep, Hans F.M. Pruijt, Leander van Gerven, Allert H. Vos, Frans Erdkamp, Willemien G. van Leeuwen-Breuk, Alexander de Graeff

المصدر: iScience, Vol 27, Iss 8, Pp 110425- (2024)

مصطلحات موضوعية: Cancer, Clinical genetics, Oncology, Science

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S258900422401650X; https://doaj.org/toc/2589-0042

URL الوصول: https://doaj.org/article/3dae747c44804a5fafa1281b33a3c21c

المؤلفون: Jacoba P. M. van der Loos, Frans Bossink, Filip Y. Fl de Vos, Willem Blokland, Michael Scherer-Rath, Wim G. Meijer, Anneke M. Westermann, Jolanda Schrama, J.B.A.M. Schilderman, A. Kuin, Heinz-Josef Klümpen, Renske Kruizinga, Willem van de Vrande, Hantie P. Kotzé, Cecile Grootscholten, Natascha A. Wp Schrama, Hanneke W. M. van Laarhoven, Mirjam A. G. Sprangers, Iris D. Hartog, Martijn G.H. van Oijen, Francesco Kortekaas

المساهمون: External Results of UHS Researchers, Graduate School, Medical Psychology, AGEM - Re-generation and cancer of the digestive system, APH - Mental Health, APH - Personalized Medicine, CCA - Cancer Treatment and Quality of Life, Oncology, AGEM - Digestive immunity, AGEM - Endocrinology, metabolism and nutrition, APH - Methodology, APH - Quality of Care, APH - Aging & Later Life

المصدر: Palliative Medicine, 33(2), 221. SAGE Publications Ltd
Palliative Medicine, 33, 2, pp. 221-231
Palliative Medicine, 33(2), 221-231. Sage Publications Ltd
Palliative Medicine, 33, 221-231
Palliative Medicine, 33(2), 221-231. SAGE Publications Ltd
Palliative Medicine
Palliative medicine, 33(2), 221-231. SAGE Publications Ltd

مصطلحات موضوعية: Male, Palliative care, NETHERLANDS, Spiritual Therapies, law.invention, 0302 clinical medicine, Randomized controlled trial, QUALITY-OF-LIFE, law, Neoplasms, Surveys and Questionnaires, ANXIETY, Medicine, 030212 general & internal medicine, Aged, 80 and over, palliative care, Life events, General Medicine, Middle Aged, DEPRESSION, spirituality, Oncology, Patient Satisfaction, 030220 oncology & carcinogenesis, randomized controlled trials, Anxiety, Female, Spiritual care, medicine.symptom, Goals, Attitude to Death, CONTINGENCY, RELIGION, 03 medical and health sciences, Quality of life (healthcare), Nursing, SUPPORTIVE CARE, Humans, Reflection (computer graphics), Aged, Center for Religion and Contemporary Society (CRCS), business.industry, Original Articles, Advanced cancer, Anesthesiology and Pain Medicine, spiritual care, spiritual care givers, Quality of Life, EXPERIENCE, business

وصف الملف: image/pdf; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e26ee7386a62219320879fe833175d2
https://doi.org/10.1177/0269216318816005

المؤلفون: Daan A. R. Castelijn, Jolanda Schrama, Jelle Alexander van Erven

المصدر: BMJ Case Rep

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Hyperviscosity, 030204 cardiovascular system & hematology, Capillary leak, Sepsis, 03 medical and health sciences, 0302 clinical medicine, Rare Disease, hemic and lymphatic diseases, Intensive care, Internal medicine, medicine, Humans, Systemic capillary leak syndrome, Splenic Infarction, Aged, business.industry, Dysarthria, Immunoglobulins, Intravenous, Shock, General Medicine, medicine.disease, 030104 developmental biology, Distributive shock, Reperfusion Injury, Shock (circulatory), Splenic infarction, Cardiology, Female, medicine.symptom, business, Capillary Leak Syndrome

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b2ecbaa7cffc8bd3ce580a035e09058
https://doi.org/10.1136/bcr-2019-232500

المؤلفون: Maud M. Geenen, Martijn M. Stuiver, Jetkse M. Meerum Terwogt, Hanna van Waart, Simone M. van den Heiligenberg, Jolanda Schrama, Marianne de Maaker-Berkhof, Jeannette A. J. H. H. Hellendoorn-van Vreeswijk, Willem H. van Harten, Edwin Geleijn, Neil K. Aaronson, Gabe S. Sonke

المساهمون: Health Technology & Services Research, APH - Health Behaviors & Chronic Diseases, APH - Quality of Care, Master Evidence Based Practice, CCA - Cancer Treatment and Quality of Life, Amsterdam Movement Sciences - Rehabilitation & Development, CCA - Cancer Treatment and quality of life, Rehabilitation medicine, Psychology Other Research (FMG)

المصدر: International journal of colorectal disease, 33(1), 29-40. Springer
International journal of colorectal disease, 33(1), 29-40. Springer Verlag
International Journal of Colorectal Disease, 33(1), 29-40. Springer Verlag
van Waart, H, Stuiver, M M, van Harten, W H, Geleijn, E, de Maaker-Berkhof, M, Schrama, J, Geenen, M M, Meerum Terwogt, J M, van Den Heiligenberg, S M, Hellendoorn-van Vreeswijk, J A J H, Sonke, G S & Aaronson, N K 2018, ' Recruitment to and pilot results of the PACES randomized trial of physical exercise during adjuvant chemotherapy for colon cancer ', International Journal of Colorectal Disease, vol. 33, no. 1, pp. 29-40 . https://doi.org/10.1007/s00384-017-2921-6

مصطلحات موضوعية: Male, medicine.medical_specialty, Randomization, Colorectal cancer, Physical fitness, UT-Hybrid-D, Pilot Projects, Physical exercise, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Humans, Aerobic exercise, Medicine, Muscle Strength, Adverse effect, Exercise, Fatigue, Demography, business.industry, Gastroenterology, Cancer, 030229 sport sciences, Middle Aged, medicine.disease, n/a OA procedure, Treatment Outcome, Chemotherapy, Adjuvant, Physical Fitness, 030220 oncology & carcinogenesis, Colonic Neoplasms, Quality of Life, Physical therapy, Patient Compliance, Female, Self Report, business, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82a31a75def606953726965a9b5e831d
https://research.utwente.nl/en/publications/afa37605-9abb-4e26-986e-91966fc5d873

المؤلفون: Marianne de Maaker-Berkhof, Jeanette A.J.H. Hellendoorn-van Vreeswijk, Simone M. van den Heiligenberg, Neil K. Aaronson, Jolanda Schrama, Laurien M. Buffart, Maud M. Geenen, Carolien H. Smorenburg, Aart van Bochove, Gabe S. Sonke, Jetske M. Meerum Terwogt, Epie Boven, Edwin Geleijn, Willem H. van Harten, Martijn M. Stuiver, Hanna van Waart, Jacobien M. Kieffer, Vera Lustig

المساهمون: APH - Amsterdam Public Health, Master Evidence Based Practice, Health Technology & Services Research, Klinische Psychologie (Psychologie, FMG), Rehabilitation medicine, Epidemiology and Data Science, Medical oncology, EMGO - Musculoskeletal health, CCA - Quality of life

المصدر: Journal of clinical oncology, 33(17), 1918-1927. American Society of Clinical Oncology
Journal of clinical oncology, 33(17), 1918-1929. American Society of Clinical Oncology
Journal of Clinical Oncology, 33(17), 1918-1927. American Society of Clinical Oncology
van Waart, H, Stuiver, M M, van Harten, W H, Geleijn, E, Kieffer, J M, Buffart, L M, de Maaker-Berkhof, M, Boven, E, Schrama, J, Geenen, M M, Terwogt, J M M, Van Bochove, A, Lustig, V, van den Heiligenberg, S M, Smorenburg, C H, Hellendoorn-van Vreeswijk, J A J H, Sonke, G S & Aaronson, N K 2015, ' Effect of Low-Intensity Physical Activity and Moderate-to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial ', Journal of Clinical Oncology, vol. 33, no. 17, pp. 1918-1927 . https://doi.org/10.1200/JCO.2014.59.1081

مصطلحات موضوعية: Adult, Cancer Research, medicine.medical_specialty, Vomiting, Health Status, medicine.medical_treatment, Physical fitness, Pain, Breast Neoplasms, Physical exercise, Motor Activity, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, law.invention, Breast cancer, Quality of life, Randomized controlled trial, law, Activities of Daily Living, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Aerobic exercise, Muscle Strength, Exercise, Fatigue, Aged, Chemotherapy, business.industry, Nausea, Middle Aged, Trastuzumab, medicine.disease, Exercise Therapy, Treatment Outcome, Oncology, Chemotherapy, Adjuvant, Physical Fitness, Quality of Life, Physical therapy, Female, Self Report, business, Adjuvant, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b04f47c8177df110ac2d07ac143472e
https://doi.org/10.1200/jco.2014.59.1081

المؤلفون: van Waart H; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., Stuiver MM; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., van Harten WH; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., Geleijn E; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., Kieffer JM; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., Buffart LM; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., de Maaker-Berkhof M; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., Boven E; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., Schrama J; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., Geenen MM; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., Meerum Terwogt JM; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., van Bochove A; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., Lustig V; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., van den Heiligenberg SM; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., Smorenburg CH; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., Hellendoorn-van Vreeswijk JA; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., Sonke GS; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands., Aaronson NK; Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands. n.aaronson@nki.nl.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2015 Jun 10; Vol. 33 (17), pp. 1918-27. Date of Electronic Publication: 2015 Apr 27.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Exercise* , Exercise Therapy* , Fatigue*/prevention & control , Motor Activity* , Physical Fitness*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use, Activities of Daily Living ; Adult ; Aged ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Breast Neoplasms/drug therapy ; Chemotherapy, Adjuvant ; Drug Administration Schedule ; Female ; Follow-Up Studies ; Health Status ; Humans ; Middle Aged ; Muscle Strength ; Nausea/chemically induced ; Nausea/prevention & control ; Pain/etiology ; Pain/prevention & control ; Quality of Life ; Self Report ; Trastuzumab ; Treatment Outcome ; Vomiting/chemically induced ; Vomiting/prevention & control